A comprehensive analysis of the fatal toxic effects associated with CD19 CAR-T cell therapy.

Cai, Changjing; Tang, Diya; Han, Ying; Shen, Edward; Abdihamid, Omar; Guo, Cao; Shen, Hong; Zeng, Shan

Cai, Changjing; Tang, Diya; Han, Ying; Shen, Edward; Abdihamid, Omar; Guo, Cao; Shen, Hong; Zeng, Shan.

Afiliación

Cai C; Department of Oncology, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
Tang D; Key Laboratory for Molecular Radiation Oncology of Hunan Province, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
Han Y; Department of Oncology, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
Shen E; Key Laboratory for Molecular Radiation Oncology of Hunan Province, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
Abdihamid O; Department of Oncology, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
Guo C; Key Laboratory for Molecular Radiation Oncology of Hunan Province, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
Shen H; Department of Life Science, McMaster University, Hamilton, ON L8S 4L8, Canada.
Zeng S; Department of Oncology, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.

Aging (Albany NY) ; 12(18): 18741-18753, 2020 Sep 24.

Article en En | MEDLINE | ID: mdl-32973124

Palabras clave

CD19 CAR-T cell therapy; fatal toxic effects; hematological malignancies; immunotherapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies / Systematic_reviews Idioma: En Revista: Aging (Albany NY) Asunto de la revista: GERIATRIA Año: 2020 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google